FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2985361774> ?p ?o ?g. }

• W2985361774 endingPage "626" @default.
• W2985361774 startingPage "620" @default.
• W2985361774 abstract "Meningitis due to Cryptococcus neoformans is responsible for upwards of 180,000 deaths worldwide annually, mostly in immunocompromised individuals. Currently there are no licensed fungal vaccines, and even with anti-fungal drug treatment, cryptococcal meningitis is often fatal. Our lab previously demonstrated vaccination with recombinant cryptococcal proteins delivered in glucan particles (GPs) protects mice against an otherwise lethal infection. The aim of the present study was to discover additional cryptococcal antigens affording vaccine-mediated protection. Sixteen proteins, each with evidence of extracellularity, were selected for in vivo testing based on their abundance in protective alkaline extracts of an acapsular C. neoformans strain, their known immunogenicity, and/or their high transcript level during human infection. Candidate antigens were recombinantly expressed in E. coli, purified and loaded into GPs. BALB/c and C57BL/6 mice received three subcutaneous injections of GP-based vaccine, and survival was assessed for 84 days following a lethal orotracheal challenge with strain KN99. As with our six published GP-vaccines, we saw differences in overall protection between mouse strains such that BALB/c mice typically demonstrated better survival than C57BL/6 mice. From these studies, we identified seven new proteins which, when administered as GP-vaccines, protect BALB/c and/or C57BL/6 mice against cryptococcal infection. With these results, we expand the pool of novel protective antigens to eleven proteins and demonstrate the potential for selection of highly transcribed extracellular proteins as vaccine targets. These screens highlight the efficacy of GP-subunit vaccines and identify promising antigens for further testing in anti-cryptococcal, multi-epitope vaccine formulations." @default.
• W2985361774 created "2019-11-22" @default.
• W2985361774 creator A5021951350 @default.
• W2985361774 creator A5035268981 @default.
• W2985361774 creator A5054141043 @default.
• W2985361774 creator A5056742280 @default.
• W2985361774 creator A5081023775 @default.
• W2985361774 creator A5081928892 @default.
• W2985361774 creator A5082676196 @default.
• W2985361774 date "2020-01-01" @default.
• W2985361774 modified "2023-10-09" @default.
• W2985361774 title "Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens" @default.
• W2985361774 cites W1568922103 @default.
• W2985361774 cites W1943178454 @default.
• W2985361774 cites W1994282287 @default.
• W2985361774 cites W2010165614 @default.
• W2985361774 cites W2017758723 @default.
• W2985361774 cites W2040223252 @default.
• W2985361774 cites W2055792787 @default.
• W2985361774 cites W2069248497 @default.
• W2985361774 cites W2077312152 @default.
• W2985361774 cites W2079401244 @default.
• W2985361774 cites W2081856420 @default.
• W2985361774 cites W2082120419 @default.
• W2985361774 cites W2104096093 @default.
• W2985361774 cites W2104281761 @default.
• W2985361774 cites W2111314562 @default.
• W2985361774 cites W2123929130 @default.
• W2985361774 cites W2125636530 @default.
• W2985361774 cites W2132217769 @default.
• W2985361774 cites W2138465665 @default.
• W2985361774 cites W2153619807 @default.
• W2985361774 cites W2161746138 @default.
• W2985361774 cites W2162544165 @default.
• W2985361774 cites W2167378317 @default.
• W2985361774 cites W2219979778 @default.
• W2985361774 cites W2563625422 @default.
• W2985361774 cites W2611697423 @default.
• W2985361774 cites W2748358597 @default.
• W2985361774 cites W2768821520 @default.
• W2985361774 cites W2790546589 @default.
• W2985361774 cites W2799394015 @default.
• W2985361774 cites W2799916498 @default.
• W2985361774 cites W2802139789 @default.
• W2985361774 cites W2901914345 @default.
• W2985361774 doi "https://doi.org/10.1016/j.vaccine.2019.10.051" @default.
• W2985361774 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6954324" @default.
• W2985361774 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31699504" @default.
• W2985361774 hasPublicationYear "2020" @default.
• W2985361774 type Work @default.
• W2985361774 sameAs 2985361774 @default.
• W2985361774 citedByCount "28" @default.
• W2985361774 countsByYear W29853617742020 @default.
• W2985361774 countsByYear W29853617742021 @default.
• W2985361774 countsByYear W29853617742022 @default.
• W2985361774 countsByYear W29853617742023 @default.
• W2985361774 crossrefType "journal-article" @default.
• W2985361774 hasAuthorship W2985361774A5021951350 @default.
• W2985361774 hasAuthorship W2985361774A5035268981 @default.
• W2985361774 hasAuthorship W2985361774A5054141043 @default.
• W2985361774 hasAuthorship W2985361774A5056742280 @default.
• W2985361774 hasAuthorship W2985361774A5081023775 @default.
• W2985361774 hasAuthorship W2985361774A5081928892 @default.
• W2985361774 hasAuthorship W2985361774A5082676196 @default.
• W2985361774 hasBestOaLocation W29853617742 @default.
• W2985361774 hasConcept C104317684 @default.
• W2985361774 hasConcept C147483822 @default.
• W2985361774 hasConcept C159047783 @default.
• W2985361774 hasConcept C203014093 @default.
• W2985361774 hasConcept C22070199 @default.
• W2985361774 hasConcept C2777893358 @default.
• W2985361774 hasConcept C2779413141 @default.
• W2985361774 hasConcept C2780868878 @default.
• W2985361774 hasConcept C2781030883 @default.
• W2985361774 hasConcept C40767141 @default.
• W2985361774 hasConcept C55493867 @default.
• W2985361774 hasConcept C86803240 @default.
• W2985361774 hasConcept C89423630 @default.
• W2985361774 hasConceptScore W2985361774C104317684 @default.
• W2985361774 hasConceptScore W2985361774C147483822 @default.
• W2985361774 hasConceptScore W2985361774C159047783 @default.
• W2985361774 hasConceptScore W2985361774C203014093 @default.
• W2985361774 hasConceptScore W2985361774C22070199 @default.
• W2985361774 hasConceptScore W2985361774C2777893358 @default.
• W2985361774 hasConceptScore W2985361774C2779413141 @default.
• W2985361774 hasConceptScore W2985361774C2780868878 @default.
• W2985361774 hasConceptScore W2985361774C2781030883 @default.
• W2985361774 hasConceptScore W2985361774C40767141 @default.
• W2985361774 hasConceptScore W2985361774C55493867 @default.
• W2985361774 hasConceptScore W2985361774C86803240 @default.
• W2985361774 hasConceptScore W2985361774C89423630 @default.
• W2985361774 hasIssue "3" @default.
• W2985361774 hasLocation W29853617741 @default.
• W2985361774 hasLocation W29853617742 @default.
• W2985361774 hasLocation W29853617743 @default.
• W2985361774 hasOpenAccess W2985361774 @default.
• W2985361774 hasPrimaryLocation W29853617741 @default.
• W2985361774 hasRelatedWork W1817460788 @default.

• next